Tissue microarray: An effective high-throughput method to study the placenta for clinical and research purposes

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 19, Issue 8, 2006, Pages 509-515

  Richani, Karina ^a   Romero, Roberto ^a,b,c   Kim, Yeon Mee ^a,b   Cushenberry, Enola ^a   Soto, Eleazar ^a   Han, Yu Mi ^a   Espinoza, Jimmy ^a,b   Kim, Chong Jai ^a,b,c  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Immunohistochemistry; In situ hybridization; Placenta; Tissue microarray

Indexed keywords

CELL NUCLEUS ANTIGEN; CHROMOGENIC SUBSTRATE; CYTOKERATIN 7; ENDOGLIN; FATTY ACID BINDING PROTEIN; MESSENGER RNA; PROTEIN ANTIBODY; PROTEIN C FOS; PROTEIN C JUN; SURFACTANT PROTEIN A; VASCULOTROPIN;

ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CYTOPLASM; FEASIBILITY STUDY; FEMALE; FETUS MEMBRANE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; MEDICAL RESEARCH; NEEDLE; PLACENTA; PLACENTA VILLUS; PRIORITY JOURNAL; SCORING SYSTEM; TISSUE MICROARRAY; TISSUE SECTION; VALIDATION STUDY; Y CHROMOSOME;

BIOLOGICAL MARKERS; BIOMEDICAL RESEARCH; DNA; FEASIBILITY STUDIES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MICROARRAY ANALYSIS; PLACENTA; PREGNANCY; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER;

EID: 33748531805     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.1080/14767050600852718     Document Type: Article

References (25)

1. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998;4: 844-847.
2. Hoos A, Cordon-Cardo C. Tissue microarray profiling of cancer specimens and cell lines: Opportunities and limitations. Lab Invest 2001;81:1331-1338.
3. Bhargava R, Lal P, Chen B. Feasibility of using tissue microarrays for the assessment of HER-2 gene amplification by fluorescence in situ hybridization in breast carcinoma. Diagn Mol Pathol 2004;13:213-216.
4. Bhargava R, Oppenheimer O, Gerald W, Jhanwar SC, Chen B. Identification of MYCN gene amplification in neuroblastoma using chromogenic in situ hybridization (CISH): An alternative and practical method. Diagn Mol Pathol 2005;14:72-76.
5. Battifora H. The multitumor (sausage) tissue block: Novel method for immunohistochemical antibody testing. Lab Invest 1986;55:244-248.
6. Simon R, Mirlacher M, Sauter G. Tissue microarrays. Methods Mol Med 2005;131:257-268.
7. Tzankov A, Went P, Zimpfer A, Dirnhofer S. Tissue microarray technology: Principles, pitfalls and perspectives-lessons learned from hematological malignancies. Exp Gerontol 2005;40:737-744.
8. Chang E, Lee A, Lee E, Lee H, Shin O, Oh S, Kang C. HER-2/neu oncogene amplification by chromogenic in situ hybridization in 130 breast cancers using tissue microarray and clinical follow-up studies. J Korean Med Sci 2004;19:390-396.
9. Chung JY, Braunschweig T, Baibakov G, Galperin M, Ramesh A, Skacel M, Gannot G, Knezevic V, Hewitt S. Transfer and multiplex immunoblotting of a paraffin embedded tissue. Proteomics 2006;6:767-774.
10. Sallinen SL, Sallinen PK, Haapasalo HK, Helin HJ, Helen PT, Schraml P, Kallioniemi OP, Kononen J. Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques. Cancer Res 2000;60: 6617-6622.
11. Nocito A, Bubendorf L, Tinner EM, Suess K, Wagner U, Forster T, Kononen J, Fijan A, Bruderer J, Schmid U, et al. Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade. J Pathol 2001;194:349-357.
12. Rubin MA, Dunn R, Strawderman M, Pienta KJ. Tissue microarray sampling strategy for prostate cancer biomarker analysis. Am J Surg Pathol 2002;26:312-319.
13. Lee P, Rosen DG, Zhu C, Silva EG, Liu J. Expression of progesterone receptor is a favorable prognostic marker in ovarian cancer. Gynecol Oncol 2005;96:671-677.
14. Fowler JM, Ramirez N, Cohn DE, Kelbick N, Pavelka J, Ben Shachar I, Morrison C. Correlation of cyclooxygenase-2 (COX-2) and aromatase expression in human endometrial cancer: Tissue microarray analysis. Am J Obstet Gynecol 2005;193:1262-1271.
15. Camp RL, Charette LA, Rimm DL. Validation of tissue microarray technology in breast carcinoma. Lab Invest 2000;80:1943-1949.
16. Hoos A, Urist MJ, Stojadinovic A, Mastorides S, Dudas ME, Leung DH, Kuo D, Brennan MF, Lewis JJ, Cordon-Cardo C. Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors. Am J Pathol 2001;158:1245-1251.
17. Chiesa-Vottero AG, Rybicki LA, Prayson RA. Comparison of proliferation indices in glioblastoma multiforme by whole tissue section vs. tissue microarray. Am J Clin Pathol 2003;120:902-908.
18. Jourdan F, Sebbagh N, Comperat E, Mourra N, Flahault A, Olschwang S, Duval A, Hamelin R, Flejou JF. Tissue microarray technology: Validation in colorectal carcinoma and analysis of p53, hMLH1, and hMSH2 immunohistochemical expression. Virchows Arch 2003;443:115-121.
19. Tzankov A, Zimpfer A, Pehrs AC, Lugli A, Went P, Maurer R, Pileri S, Dirnhofer S. Expression of B-cell markers in classical Hodgkin lymphoma: A tissue microarray analysis of 330 cases. Mod Pathol 2003;16:1141-1147.
20. Watanabe A, Cornelison R, Hostetter G. Tissue microarrays: Applications in genomic research. Expert Rev Mol Diagn 2005;5:171-181.
21. Packeisen J, Korsching E, Herbst H, Boecker W, Buerger H. Demystified...tissue microarray technology. Mol Pathol 2003;56:198-204.
22. Shergill IS, Shergill NK, Arya M, Patel HR. Tissue microarrays: A current medical research tool. Curr Med Res Opin 2004;20:707-712.
23. Fonsatti E, Del Vecchio L, Altomonte M, Sigalotti L, Nicotra MR, Coral S, Natali PG, Maio M. Endoglin: An accessory component of the TGF-beta-binding receptor-complex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignancies. J Cell Physiol 2001;188:1-7.
24. Gougos A, Letarte M. Primary structure of endoglin, an RGD-containing glycoprotein of human endothelial cells. J Biol Chem 1990;265:8361-8364.
25. Lawrence JB, Singer RH. Quantitative analysis of in situ hybridization methods for the detection of actin gene expression. Nucleic Acids Res 1985;13:1777-1799.